Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Mobile ECG Devices Market, by Modality
1.4.2 LAMEA Mobile ECG Devices Market, by End-use
1.4.3 LAMEA Mobile ECG Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Apr – 2023, Oct) Leading Players
4.4 Porter’s Five Force Analysis
Chapter 5. LAMEA Mobile ECG Devices Market, by Modality
5.1 LAMEA Handheld Market, by Country
5.2 LAMEA Band Market, by Country
5.3 LAMEA Pen Market, by Country
5.4 LAMEA Others Market, by Country
Chapter 6. LAMEA Mobile ECG Devices Market, by End-use
6.1 LAMEA Hospitals & Diagnostic Centers Market, by Country
6.2 LAMEA Ambulatory Care Market, by Country
6.3 LAMEA Homecare Market, by Country
Chapter 7. LAMEA Mobile ECG Devices Market, by Country
7.1 Brazil Mobile ECG Devices Market
7.1.1 Brazil Mobile ECG Devices Market, by Modality
7.1.2 Brazil Mobile ECG Devices Market, by End-use
7.2 Argentina Mobile ECG Devices Market
7.2.1 Argentina Mobile ECG Devices Market, by Modality
7.2.2 Argentina Mobile ECG Devices Market, by End-use
7.3 UAE Mobile ECG Devices Market
7.3.1 UAE Mobile ECG Devices Market, by Modality
7.3.2 UAE Mobile ECG Devices Market, by End-use
7.4 Saudi Arabia Mobile ECG Devices Market
7.4.1 Saudi Arabia Mobile ECG Devices Market, by Modality
7.4.2 Saudi Arabia Mobile ECG Devices Market, by End-use
7.5 South Africa Mobile ECG Devices Market
7.5.1 South Africa Mobile ECG Devices Market, by Modality
7.5.2 South Africa Mobile ECG Devices Market, by End-use
7.6 Nigeria Mobile ECG Devices Market
7.6.1 Nigeria Mobile ECG Devices Market, by Modality
7.6.2 Nigeria Mobile ECG Devices Market, by End-use
7.7 Rest of LAMEA Mobile ECG Devices Market
7.7.1 Rest of LAMEA Mobile ECG Devices Market, by Modality
7.7.2 Rest of LAMEA Mobile ECG Devices Market, by End-use
Chapter 8. Company Profiles
8.1 New York Plastic Surgical Group, PC (Long Island Plastic Surgical Group, PC)
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Nihon Kohden Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Product Category and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 GE HealthCare Technologies, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.6 SWOT Analysis
8.4 Medtronic PLC
8.4.1 Company overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Trials and Approvals:
8.4.5.2 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 iRhythm Technologies, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.5.4 Recent strategies and developments:
8.5.4.1 Trials and Approvals:
8.5.5 SWOT Analysis
8.6 Koninklijke Philips N.V.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Omron Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Product Launches and Product Expansions:
8.7.5.2 Partnerships, Collaborations, and Agreements:
8.7.6 SWOT Analysis
8.8 AliveCor, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.8.2.3 Trials and Approvals:
8.8.3 SWOT Analysis
8.9 EMAY
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. Nureca Limited (Dr Trust)
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Recent strategies and developments:
8.10.3.1 Product Launches and Product Expansions:
8.10.4 SWOT Analysis
Unique Offerings 